Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60

Climacteric

Volumn 12, Issue 3, 2009, Pages 206-209

  Studd, J ^a  

^a London PMS and Menopause Centre   (United Kingdom)

Author keywords

Bisphosphonates; Collagen; Estrogens; Intravertebral Disc; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO; PROGESTERONE; TESTOSTERONE;

BONE DENSITY; BONE MATRIX; BREAST CANCER; DRUG SAFETY; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; INTERVERTEBRAL DISK; MOOD; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SEXUALITY; SHORT SURVEY; THROMBOSIS; UNSPECIFIED SIDE EFFECT; VASOMOTOR REFLEX; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; FRACTURE; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; RISK ASSESSMENT;

BONE DENSITY; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FRACTURES, BONE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK ASSESSMENT;

EID: 68949088507     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902721873     Document Type: Short Survey

References (20)

1. Studd J, Holland EF, Leather AT, Smith RN. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Br J Obstet Gynaecol 1994;101:787-791 (Pubitemid 24285198)
2. Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333
3. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 2006; 13:340-367
4. Studd J. Why are estrogens rarely used for treatment of depression in women? Gynecol Endocrinol 2007;23:63-64
5. Beral V; Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003; 362:419-427
6. Studd J. Variations on hormone replacement therapy: An answer to the 'one dose fits all' Women's Health Initiative study. Gynecol Endocrinol 2007;23:665-671
7. Davis SR, Burger HG. The rationale for physiological testosterone replacement in women. Balliere's Clin Endocrinol Metab 1998;12: 391-405
8. Horner E, Fleming J, Studd J. A study of women on long-term hormone replacement therapy and their attitude to suggested cessation. Climacteric 2006;9:459-463
9. Thunnell L, Milsom I, Schmidt J, Mattson LA. Scientific evidence changes prescribing practice - a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003. Br J Obstet Gynaecol 2006;113:15-20
10. Brincat M, Moniz CJ, Studd J, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92:256-259
11. Brincat MP, Calleja-Agius J, Baron YM. The skin, carotid and intervertebral disc: Making the connection! Climacteric 2007;10(Suppl 2):83-87
12. Khastgir G, Studd JWW, Holland N, et al. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. J Clin Endocrinol Metab 2001;86:289-295 (Pubitemid 32109808)
13. Khastgir G, Studd J, Holland N, et al. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis. Osteoporosis Int 2001; 12:465-470 (Pubitemid 32607089)
14. Muscat Baron Y, Brincat MP, Galea R, Calleja N. Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures. Climacteric 2007;10:314-319
15. Banks E, Beral V, Reeves G, et al. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA 2004;291:2212-2220
16. Bagger YZ, Tanko LB, Alexandersen P, et al. Two to three years of hormone replacement treatment in healthy women has long term preventative effects on bone mass and osteoporotic fractures: The PERF study. Bone 2004; 34:728-735
17. Whitehead M, Farmer R. The Million Women Study - a critique. Endocrine 2004;24:187-193
18. Manson JE, Hsai J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534
19. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712
20. Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. Br Med J 2008;336:1227-1231